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oncurrent infectionof different dengue virus serotypes in fatal
ases during an outbreak in Colombia, 2010
. Méndez1,∗, L. Pardo2, G. Rey-Benito3
Instituto Nacional de Salud, 01, Bogotá, Colombia
Instituto nacional de Salud, Bogotá, Colombia
Instituto Nacional de Salud, Bogotá, Colombia
Background: Dengue virus (DENV) is an arthropod borne ﬂa-
ivirus responsible of a major viral re-emergent disease in tropical
nd sub-tropical countries, affecting about50millionpeople at year
round the world. In Colombia dengue outbreaks occurs every ﬁve
r six year, but the infection is endemic and constantly reported in
ost of the country. During the last year, Colombia went through
he largest dengue epidemic occurred in decades, with 157.152
ases notiﬁed, 217 deaths conﬁrmed and all four viral serotypes
o-circulating.
Methods: Samples from two fatal cases (serum fromonepatient
nd tissue from the other one) were tested by RT-PCR using sepa-
ate dengue type speciﬁc primers.
Results: Gel electrophoresis demonstrated ampliﬁcation with
wodifferent serotypes (DENV2/DENV3andDENV2/DENV4respec-
ively). Results were conﬁrmed by sequence of the ampliﬁed
ragments and further analysis in theBasic Local Alignement Search
ool (BLAST).
Conclusion: Although the co-circulation of all 4 dengue
erotypes is common in highly endemic areas, concurrent infection
ith 2 different serotypes remains as a very unusual event. This is
he ﬁrst report of dengue co-infection in fatal cases in Colombia.
evertheless, the role of concurrent infection in severity of the
isease should be further established.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.312
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reviewof laboratory-conﬁrmed cases of humanparainﬂuenza
iruses in Kenya (2007-2011)
. Mitei1,∗, W. Bulimo2, R. Achilla2, J. Majanja2, J. Mwangi2, J.
jiri 2, E. Wurapa2
USAMRU-Kenya, Nairobi, Kenya
USAMRU-K, Nairobi, Kenya
Background: Human parainﬂuenza viruses (HPIVs) account for
large percentage of pediatric respiratory infections, including
pper respiratory tract infections (URTIs), laryngotracheobronchi-
is (croup), bronchiolitis, and pneumonia. HPIV is the major cause
f croup (type 1 is most frequent, followed by type 3 and type 2).
uman parainﬂuenza viruses are divided into 4 types, all of whichnfectious Diseases 16S (2012) e2–e157
are classiﬁed as paramyxoviruses. Infections from types 1 and 3
account for most disease.
In May 2007 through an existing inﬂuenza surveillance net-
work, the Kenyan National Inﬂuenza center started screening for
Parainﬂuenza Viruses.
Methods:Nasopharyngeal swab specimenswere collected from
consenting patients ≥ 2 months old meeting the WHO ILI Case
deﬁnitionand transported to theKenyanNICwhere theywere inoc-
ulated into LLC-MK2 cell line. After observing cells for Cytopathic
effect, sampleswere analyzed by direct immunoﬂuorescence assay
(IFA) performed using the Respiratory Panel I Viral Screening and
Identiﬁcationkit (Chemicon International, Inc.), following theman-
ufacturer’s instructions, for detecting antigens of HPIV-1, 2 and
3.
Results: A total of 15,540 samples of nasopharyngeal swabs
were collected from July 2006 -October 2011. Respiratory
pathogens were detected in 3, 432 cases representing 22.1% and
801 (23.3%) were HPIV. HPIV- 3 was the most frequent detected
type among HPIV-positive cases accounting for 361 (45.0%) cases;
HPIV-1 and HPIV-2 were detected in 296 (37.0%) cases and 144
(18.0%) cases respectively. Analyses of co-infection pairs showed
that HPIV and FLUAV are the most common paired viruses with
HPIV3having the highest number; 28 cases followedbyHPIV1with
a total of total number of 9 cases. There were only 2 co-infections
with HPIV and pH1N1; one with HPIV- 1 and the other with HPIV2
both occurring in the year 2010. Overall, 30 cases were positive for
human parainﬂuenza 1, 2 & 3.
Conclusion: This study emphasizes the importance of contin-
ued surveillance of HPIV and reinforces the need to diagnose these
infections to provide data that are useful in control efforts and vac-
cine trials especially in developing countries where none of these
data exists. A close scrutiny of the seasonality of HPIV in Kenya will
be very vital for effective prevention and control strategies.
http://dx.doi.org/10.1016/j.ijid.2012.05.313
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Low Methicillin Resistant Staphylococcus aureus (MRSA) colo-
nization among HIV positive patients attending an outpatient
clinic in Sungai Buloh Hospital, Malaysia
S.F.A.MohdNawi1,∗, S. Kumar2, A. Adnan1, Z.MohdZain1, C. Lee2
1 Faculty of Medicine, Universiti Teknologi Mara (UiTM) Shah Alam,
Shah Alam, Selangor, Malaysia
2 Hospital Sungai Buloh„ Sungai Buloh, Selangor, Selangor, Malaysia
Background: Methicillin Resistant Staphylococcus aureus
(MRSA) is a multi-drug resistant bacterium which can cause a
variety of conditions from mild to life-threatening skin and soft
tissue infections. MRSA colonizers are prone to develop infections.
The colonization rates in the general population vary from < 1%
in Northern Europe to > 40% in Southern and Western Europe.
In the United States, HIV positive patients were found to have a
6-fold increase in MRSA colonization rates when compared with
non-HIV infected patients. To date, there is no published data on
MRSA screening among HIV patients in this country. The purpose
of this study is to determine the rates of MRSA colonization among
HIV positive patients in our population.
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Methods: 130 HIV positive patients had swabs taken during an
utpatient clinic visit in Sungai Buloh Hospital. The swabs were
aken from four different sites (anterior nares, throat, axilla and
kin) from each patient. Each of these swabs was streaked on
annitol Salt Agar (MSA) and incubated overnight. S. aureus was
dentiﬁed was based on standard microbiological methods. The
ntibiotic susceptibility testing (AST) was performed and inter-
retedaccording to theClinical Laboratory Standard Institute (CLSI)
011 guidelines.
Results: A total of 520 swabs were collected from 130 patients.
9 swabs which was taken from 45 patients had S. aureus. 30 of
hese swabs were from anterior nares; 20, 12 and 7 swabs were
rom the throat, skin and axilla respectively. Anterior nare swabs
icked up 66.7% (30/45) of the carriers. Throat swabs picked up an
dditional 20% (9/45). Skin and axillary swabs picked up another
dditional 13% (6/45) and 4% (2/45). There was only one S. aureus
solate which was found to be MRSA. It showed resistance to
enicillin, oxacillin, erythromycin, clindamycin and trimethoprim-
ulphamethoxazole.
Conclusion: While the Staphylococcus aureus carrier rate in this
IV positive populationwas 34.6% (45/130), the incidence ofMRSA
as only 2.2% (1/45). In this study, sampling from different sites
er patient increased the yield of positive results. The most useful
itewas the anterior nares, however swabbing anterior nares alone
ould have missed 33.3% of the carriers.
ttp://dx.doi.org/10.1016/j.ijid.2012.05.314
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nitial spatial and temporal distribution/dynamics of pandemic
1N1 inﬂuenza virus in Kenya between August 2009 and
ecember 2010
. Muthoni1,∗, W. Bulimo2, R. Achilla2, J. Majanja2, J. Njiri 2,
. Wadegu2, S. Mukunzi2, J. Mwangi2, B. Opot2, F. Osuna2, E.
urapa2
US Army medical research unit, Kenya, Nairobi, Kenya
USAMRU-K, Nairobi, Kenya
Background: The pandemic Inﬂuenza A/H1N1 virus (A[H1N1]
dm)wasﬁrst identiﬁed inKenya in June2009. Since then, the virus
as spread throughout the country and even dominated previously
irculating inﬂuenza A subtypes.
Methods: 4,679 Nasopharyngeal (NP) swabs specimens were
ollected between August 2009 and August 2010 from consenting
atients meeting the WHO Inﬂuenza like illness (ILI) case deﬁni-
ion and transported to the National Inﬂuenza Centre in Nairobi.
etection of seasonal Inﬂuenza B, A/H1N1, A/H3N2, A/H5N1 and
andemic Inﬂuenza A/H1N1 viruses was carried out using Ag Path-
DTM One step Real Time polymerase chain reaction (RT PCR)
eagents together with CDC Inﬂuenza virus RT PCR detection and
haracterization panels.
Results: The ﬁrst case of A[H1N1] pdm was detected in Kenya
n June 2009 while the ﬁrst case in our sentinel sites occurred in
ugust 2009. During the period under study, 258 (5.5%) samples
ere positive for A[H1N1] pdm. Due to sustained transmission of
he virus after the ﬁrst case, an epidemic peak of the virus was
oted from September to November 2009. However, laboratory-nfectious Diseases 16S (2012) e2–e157 e139
conﬁrmed cases of the virus varied in time from a high of 25% in
October 2009 to a low of 0% in April, May and July 2010. Malindi
had the highest number of laboratory conﬁrmed cases of A[H1N1]
pdm at 12% of samples collected in that site during that period
while at 1.4% Alupe had the lowest number of conﬁrmed cases.
The ﬁrst reported cases were associated with international travel;
however, the virus quickly established itself locally with sustained
transmission occurring within two months of the ﬁrst case, which
was followed by an exponential increase in case numbers.
Conclusion: Understanding the spatial and temporal distribu-
tion and dynamics of pandemic A/H1N1 Inﬂuenza virus may prove
useful in future pandemic planning.
http://dx.doi.org/10.1016/j.ijid.2012.05.315
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Inﬂuenza and inﬂuenza like illness in human populations in
Uganda
E. Mworozi1,∗, D. Byarugaba2, B. Erima3, J. Bwogi4, L. Luswa5, D.
Mimbe6, M. Milland6, H. Kibuuka6, W. Mangeni7
1 Mulago National Referral Hospital, Kampala, Uganda
2 Makerere University, Kampla, Uganda
3 Makerere UniversityWalter Red Project(MUWRP), Kampala, Uganda
4 Uganda Virus Research Institute, Entebbe, Uganda
5 Ministry Of Health, Kampala, Uganda
6 MUWRP, Kampala, Uganda
7 Makerere University, Kampala, Uganda
Background: Following the outbreaks of the pathogenic
inﬂuenza virus subtype H5N1 in 2006 and later the Pandemic
Inﬂuenza A (H1NI). in 2009, Makerere University Walter Reed
Project (MUWRP) with the Ministry of Health and partners
undertook surveillance for and Inﬂuenza like illnesses (ILIs) in pop-
ulations in Uganda to detect potential strains.
To conduct surveillance of inﬂuenza and inﬂuenza-like illnesses
in human populations in Uganda and detect circulating inﬂuenza
strains and map the populations at risk of pandemic inﬂuenza
threats and control them.
Methods: From 0ctober 2008 to May 2011, patients aged 6
monthsor older presenting inﬂuenzaor ILIs iewith fever (> 38oCel-
sius) plus cough and/or cold and/or sore-throat within 72 hrs were
enrolled at 5 outpatient sentinel sites after obtaining informed con-
sent (assent for children 8-17 years). Demographic, social, travel,
work and exposure history to birds and/or animals was taken, and
a physical examination was done. A throat and/or nasopharyngeal
swab was collected for virus isolation and typing using RT-PCR for
ﬂu A and B.
Results:A total of 3547participantswere enrolled; 1797 (50.7%)
were females, 2875 (81.1%) and 307 (8.7%)were chidren under 5yrs
and 6 -17. The majority, 3070 of the 3547 (86.6%) tested negative
on RT-PCR screening for Flu A&B,while 368 (10.4%) patients tested
positive for Flu A, and 102/3547 (2.9%) tested positive for Flu B. On
subtyping for Flu A, 5 (1.9%) were H1,84 (32.6%) were H3 and 39
(2.1%) had co-infections of H3 and HINI was present in 90 (34.9%)
andH3N2 in 53 (20.5%) specimens,while 23 (8.9%)were untypable.
Subtyping for Flu B is still ongoing. By gender, females contributed
130/258 (50.4%) subtypes of Flu A while by age, children under ﬁve
